Safety profile assessment of HPV4 and HPV9 vaccines through the passive surveillance system of the Veneto Region (Italy) between 2008 and 2022: A 15-year retrospective observational study

In Veneto Region, HPV vaccine has been actively offered to 12 year-old females since 2008, and to 12 year-old males since 2015. The study aims to analyze the safety profile of HPV4v and HPV9v vaccines and perform a case-by-case review of conditions of interest.Spontaneous reports related to HPV uplo...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Diana Dalla Valle, Roberto Benoni, Nicola Soriolo, Chiara Battistella, Francesca Moretti, Laura Augusta Gonella, Stefano Tardivo, Silvia Colpo, Sara Montresor, Francesca Russo, Michele Tonon, Filippo Da Re, Ugo Moretti, Giovanna Zanoni
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Elsevier 2024-08-01
Rangatū:	Vaccine: X
Ngā marau:	Human papilloma virus vaccine Adolescent health Postmarketing product surveillance Adverse drug reaction reporting system Adverse drug event Primary disease prevention
Urunga tuihono:	http://www.sciencedirect.com/science/article/pii/S2590136224000846
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!